Renishaw Achieves Record Revenue and Strategic Progress Amid Market Challenges

Renishaw ( (GB:RSW) ) has provided an update.

Renishaw reported record revenue of £713.0 million for FY2025, a 3.1% increase from the previous year, despite challenging market conditions. The company achieved a 3.8% rise in adjusted profit before tax and maintained stable operating profit margins. Strategic initiatives included new product introductions, exiting the neurological drug delivery business, and implementing cost reduction measures, such as a £20 million annualized payroll reduction. These efforts are aimed at supporting future growth and improving margins. The company also proposed a 2.5% increase in the full-year dividend, reflecting confidence in its long-term sustainable growth model.

The most recent analyst rating on (GB:RSW) stock is a Hold with a £3340.00 price target. To see the full list of analyst forecasts on Renishaw stock, see the GB:RSW Stock Forecast page.

Spark’s Take on GB:RSW Stock

According to Spark, TipRanks’ AI Analyst, GB:RSW is a Outperform.

Renishaw’s strong financial position and strategic initiatives are major strengths, supporting a solid stock performance. However, decreased net profit margins and limited dividend yield slightly offset these positives.

To see Spark’s full report on GB:RSW stock, click here.

More about Renishaw

Renishaw is a world-leading supplier of measuring and manufacturing systems, providing high accuracy and precision technology that aids customers in innovating their products and processes. The company operates globally with customer-facing locations across the Americas, EMEA, and APAC regions, while most R&D activities are based in the UK. Renishaw’s largest manufacturing sites are located in the UK, Ireland, and India.

Average Trading Volume: 116,390

Technical Sentiment Signal: Hold

Current Market Cap: £2.34B

For detailed information about RSW stock, go to TipRanks’ Stock Analysis page.